Sanofi has chosen the award-winning Burgopak slider design for its heartburn treatment
Maalox Plus is one of four products to be launched by Sanofi in the Burgopak slider design. Sanofi’s first product launch was Dolipranelib for the French OTC market in September 2010. Sanofi’s heartburn brand Maalox in flavours Menthe and Citron have also been launched. Maalox Plus will be Sanofi’s first product to be launched into the Italian market using the Burgopak slider.
The Burgopak slider’s compact size and engaging opening system is complimented by the products bright yellow outer carton and contrasting orange blister chosen by Sanofi. This combination ensures that the Maalox Plus product boldly stands out from its OTC competitors on pharmacy shelves and also aims to increase consumer brand recognition. The Burgopak slider design itself focuses on patient compliance and ensures all vital information is clearly displayed and available whenever the product is used.
The launch of Maalox Plus in Italy continues to strengthen Burgopak’s presence in the pharmaceutical & healthcare industry across different market regions. Tim Clarke, CEO of Burgopak Healthcare & Technology says: “We are delighted to continue to work with Sanofi by extending the Maalox brand using the Burgopak slider into the Italian market. This is a great compliment to the slider design and is further recognition that the Burgopak slider is appealing to consumers across the global OTC market.”
In 2008 the first automated Burgopak slider was launched into the pharmaceutical market, offering companies a unique operating system that supports patient safety and compliance, and is robust, portable and user-friendly. These innovative pharmaceutical packs incorporate Burgopak’s patented sliding mechanism, keeping the patient information booklet, the blisters containing the medication and the branded outer carton conveniently connected at all times.
Quelle: Burgopak Healthcare & Technology
